Video capsule endoscopy in overt and occult obscure gastrointestinal bleeding: Insights from a single-center, observational study in Japan.

double‐balloon enteroscopy obscure gastrointestinal bleeding (OGIB) overt and occult OGIB single‐balloon enteroscopy video capsule endoscopy

Journal

DEN open
ISSN: 2692-4609
Pays: Australia
ID NLM: 9918317682706676

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 08 12 2023
revised: 15 02 2024
accepted: 08 03 2024
medline: 3 4 2024
pubmed: 3 4 2024
entrez: 3 4 2024
Statut: epublish

Résumé

This study aimed to evaluate the use of video capsule endoscopy (VCE) in patients with obscure gastrointestinal bleeding (OGIB), compare cases of overt and occult OGIB, assess the rates of balloon-assisted enteroscopy (BAE) interventions and rebleeding, and identify predictive markers of positive VCE findings. Medical records of 430 patients who underwent VCE for OGIB between 2004 and 2022 were analyzed. Occult OGIB was defined as IDA or positive fecal occult blood, whereas overt OGIB was defined as clinically imperceptible bleeding. We retrospectively analyzed demographics, VCE findings based on Saurin classification (P0, P1, and P2), outcome of BAE interventions, and rebleeding rates. A total of 253 patients with overt OGIB and 177 with occult OGIB were included. P1 findings were predominant in both groups, with a similar distribution. The percentage of patients receiving conservative therapy was higher in P1 than in P2 for both overt and occult OGIB. BAE was more frequently performed in P2 than in P1 VCE (83.0% vs. 35.3% in overt OGIB, 84.4% vs. 24.4% in occult OGIB). The percentage of positive findings and intervention in total BAE performed patients were comparable in P1 and P2 of overt OGIB, whereas these percentages in P2 were more than P1 of occult OGIB. VCE effectively identified OGIB lesions requiring intervention, particularly occult OGIB lesions, potentially reducing unnecessary BAE. Rebleeding rates varied according to the VCE findings, emphasizing the importance of follow-up in high-risk patients.

Identifiants

pubmed: 38567032
doi: 10.1002/deo2.354
pii: DEO2354
pmc: PMC10985219
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e354

Informations de copyright

© 2024 The Authors. DEN Open published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.

Déclaration de conflit d'intérêts

Naoki Hosoe conducted the independent research supported by funding contributions from Covidien. Naoki Hosoe received a research grant from Olympus. Naoki Hosoe is an associate editor of DEN Open. The other authors declare no conflict of interest.

Auteurs

Anna Tojo (A)

Division of Gastroenterology and Hepatology Department of Internal Medicine School of Medicine Keio University Tokyo Japan.
Center for Diagnostic and Therapeutic Endoscopy School of Medicine Keio University Tokyo Japan.

Tomohisa Sujino (T)

Center for Diagnostic and Therapeutic Endoscopy School of Medicine Keio University Tokyo Japan.

Yukie Hayashi (Y)

Division of Gastroenterology and Hepatology Department of Internal Medicine School of Medicine Keio University Tokyo Japan.
Center for Diagnostic and Therapeutic Endoscopy School of Medicine Keio University Tokyo Japan.

Kenji J L Limpias Kamiya (KJLL)

Division of Gastroenterology and Hepatology Department of Internal Medicine School of Medicine Keio University Tokyo Japan.

Moe Sato (M)

Division of Gastroenterology and Hepatology Department of Internal Medicine School of Medicine Keio University Tokyo Japan.
Center for Diagnostic and Therapeutic Endoscopy School of Medicine Keio University Tokyo Japan.

Sakurai Hinako (S)

Division of Gastroenterology and Hepatology Department of Internal Medicine School of Medicine Keio University Tokyo Japan.
Center for Diagnostic and Therapeutic Endoscopy School of Medicine Keio University Tokyo Japan.

Yusuke Yoshimatsu (Y)

Division of Gastroenterology and Hepatology Department of Internal Medicine School of Medicine Keio University Tokyo Japan.

Satoshi Kinoshita (S)

Department of Gastroenterology Saitama Medical Center Saitama Japan.

Hiroki Kiyohara (H)

Division of Gastroenterology and Hepatology Department of Internal Medicine School of Medicine Keio University Tokyo Japan.

Yohei Mikami (Y)

Division of Gastroenterology and Hepatology Department of Internal Medicine School of Medicine Keio University Tokyo Japan.

Kaoru Takabayashi (K)

Center for Diagnostic and Therapeutic Endoscopy School of Medicine Keio University Tokyo Japan.

Motohiko Kato (M)

Center for Diagnostic and Therapeutic Endoscopy School of Medicine Keio University Tokyo Japan.

Haruhiko Ogata (H)

Center for Diagnostic and Therapeutic Endoscopy School of Medicine Keio University Tokyo Japan.

Takanori Kanai (T)

Division of Gastroenterology and Hepatology Department of Internal Medicine School of Medicine Keio University Tokyo Japan.

Naoki Hosoe (N)

Center for Diagnostic and Therapeutic Endoscopy School of Medicine Keio University Tokyo Japan.

Classifications MeSH